Artixio

Pharmaceutical Excipients Definition, Types & Regulatory Guidelines

Pharmaceutical Excipients Definition, Types & Regulations

A drug product gets its therapeutic effects from the active pharmaceutical ingredient (API). However, finished pharmaceutical products also have ingredients other than the API. These ingredients are called excipients. Generally, they are compounds that are physically and chemically inert and are used for various reasons. But they aren’t inert and innocuous anymore in drug formulations. They’ve become active and complex. Let’s get to know more about the pharmaceutical excipients in this article.

What Are Pharmaceutical Excipients?

Pharmaceutical excipients are substances that are an addition to the active pharmaceutical ingredient in a finished drug product. In other words, everything other than the active ingredient in a finished drug formulation is an excipient.

They are generally substances that do not provide the primary therapeutic effect but perform various functions in the formulation. These are frequently used as lubricants, diluents, binders, flavorings, coatings and coloring agents, disintegrants, and preservatives for the formulation.

Also Read: Drugs vs Medicines

Ideal Properties of Excipients

  • Should be pharmacologically inactive for its intended use
  • Should not have undesirable interactions with the drug or other formulation components
  • It must be cost-effective
  • It should be stable, non-toxic and commercially available in the countries where the product is to be manufactured.
  • Pleasing organoleptic properties, where relevant
  • Must be functional for the intended use

Classification of Excipients

Pharmaceutical excipients are classified according to the functions they perform in a pharmaceutical dosage form. An excipient may perform more than one function but it will depend on the formulation and intended use. Classification of excipients is given below:

Classification Of Excipients

Pharmaceutical Excipient Types:

Excipients are used in almost all drug products. Most commonly used pharmaceutical excipients are as follows:

Binders: As the name suggests, they are used to bind or to adhere the molecules of a formulation. It provides mechanical strength to the tablet or granules and provides integrity to the final product. Examples- Starch, Gelatin, Acacia

Disintegrating/Super Disintegrating Agents: They are added to a tablet to facilitate the breaking or disintegration of the formulation for its drug release. Examples- Croscarmellose Sodium, Crospovidone

Diluents: Increase the bulk of the tablet or capsules when the drug dosage is insufficient for the tablet to reach the required size or weight. Examples- Microcrystalline Cellulose, Lactose Monohydrate, Calcium Phosphate

Glidants: They are added to increase the flow property of the granules or powder materials. They also decrease the friction between them. Examples: Colloidal Silicon Dioxide

Lubricants: They are useful in preventing the adhesion of tablet materials to the die and punch surfaces, decreasing the friction during manufacturing. Examples- Magnesium Stearate & Talc

Coloring and Flavoring Agents: Coloring agents add color to the formulation. Flavoring agents mask the unpleasant taste of the drug product as well as improve palatability. Examples- Dyes and Pigments (Coloring Agents), Peppermint Oil, Spearmint Oil (Flavoring Agents)

Regulatory Requirements for Pharmaceutical Excipients

Regulators set forward many conditions that must be satisfied to incorporate the excipients into the pharmaceutical product.

Safety, Toxicity and Precedence of Use Issues

The guideline issued by the European Commission in support of Directive 2011/62/EC states that “quality risk management principles should be used to assess the risks presented to the quality, safety and function of each excipient and to classify the excipient in question, e.g., as low risk, medium risk or high risk.” It also determines the appropriate Good Manufacturing Practice requirements for the excipient manufacturer.

Previous use of an excipient can also provide useful information during pharmaceutical development. For e.g., In The US, precedence of use is listed in the FDA Inactive Ingredient Database (IID). The IID can be used as an aid during drug development and excipient safety assessment. However, its inclusion in the database does not constitute general approval of an excipient for all routes, dosage forms or levels of use.

Thus, the excipient manufacturers must first assess the precedence of use in countries where it is intended to be marketed.

GMP Requirements

Appropriate manufacturing controls are important for ensuring excipient quality. GMP expectations for excipient manufacture may vary depending on the applicable regulatory framework and the risk associated with the excipient and its intended use.

In the European Union, medicinal product manufacturers have to perform a documented risk evaluation. It’ll decide the relevant GMP requirements for the manufacture of excipients.

Industry guidance, such as the IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients, provides internationally recognised guidance for establishing suitable quality systems for excipient manufacture.

Reach out to us for

GMP Consulting Services

Compendial Requirements

Where included in the pharmacopoeia, the excipient must be in compliance with the monograph requirements and also the general notices. It depends on the applicable regulatory framework and intended pharmaceutical use. Multiple compendia are used across the world. The most referenced are the following:

  • USP-NF (United States Pharmacopeia – National Formulary)
  • Ph. Eur. (European Pharmacopoeia)
  • ChP (Chinese Pharmacopoeia)
  • JP (Japanese Pharmacopoeia)
  • JPE (Japanese Pharmaceutical Excipients)

For excipients not described in an applicable pharmacopoeia, additional information and justification may be required depending on the regulatory submission and intended use.

Functional Properties & Suitability for Intended Use

Excipient suppliers may maintain data that describes the physical, chemical and functional characteristics of their materials. This information can be helpful to pharmaceutical manufacturers. They can assess whether an excipient is suitable for the function it aims to perform within a particular drug formulation.

However, prior use or available functionality data alone does not establish suitability for every pharmaceutical application. The excipient should be evaluated in the context of the specific formulation and intended use.

Excipient Master Files and Other Filings

Some jurisdictions provide mechanisms for submitting confidential information relating to the manufacture, quality or safety of pharmaceutical excipients.

These mechanisms may include Drug Master Files (DMFs), Certificates of Suitability to the European Pharmacopoeia (CEPs) and other jurisdiction-specific excipient documentation procedures.

Such filings can allow confidential information to be provided to regulatory authorities in support of a medicinal product application. However, the availability and requirements of these mechanisms vary by jurisdiction.

Also Read: What Is Certification Of Suitability (CEP)

ICH Guidelines

These guidelines are applicable to drug substances and medicinal products but are not directly applicable to excipients. Nonetheless, some elements of the ICH guideline provide guidance for topics relating to excipients, such as the GMP requirements.

Specific Safety & Quality Considerations

The quality and origin of the excipients will have an impact on patient safety and religious purity. Therefore, the excipient suppliers must be knowledgeable and should have control over the origin of raw materials, degradation products of the excipients, elemental purities, residual solvents, additives and processing aids aspects of their processes.

The suitability of an excipient should ultimately be assessed according to its intended pharmaceutical use and the potential risks it may present to the finished drug product.

Safety Considerations for Excipients in Pharmaceuticals

Initially, excipients were considered safe, as they were thought to be chemically inert. But with the sulfanilamide tragedy and related experiences with pharma products, this was reversed. There is no general approval process for excipients, but it is approved together with a drug as a drug product.

Excipients can also have toxic effects. It depends on factors such as the substance, dose, route of administration and patient population. Their use should therefore be appropriately justified and controlled. Information on the safety and prior use of an excipient may be available from sources such as the FDA Inactive Ingredient Database. For novel excipients, additional safety information may be required to support their proposed use. The extent of the nonclinical safety data depends on the circumstances and the applicable regulatory requirements.

Adverse effects can occur not only due to active ingredients but also due to excipients used in the drug product. Excipients should therefore be evaluated for their suitability and potential risks in the context of the drug product, including the route of administration, dose and intended patient population.

Since the quality of the excipients has a direct impact on the drug product, GMP or applicable quality requirements must be followed. The quantity of excipients plays a role in age, especially in premature infants and children due to their developing organs. Risk-benefit assessment must be conducted for novel excipients so as to establish safety limits.

Pharmaceutical Grade Excipients and Quality Standards

Excipients used in medicines need to meet appropriate quality requirements for their intended pharmaceutical use. Where an excipient is covered by an applicable pharmacopoeial monograph, relevant requirements may include identity, purity and impurity controls. Pharmacopoeias such as the USP–NF and European Pharmacopoeia provide recognised quality standards for substances covered by their monographs.

Quality isn’t just about chemistry, though. Manufacturers must also follow GMP and applicable quality controls to show the material is produced under controlled, consistent conditions. This way, companies know the excipient they’re using won’t introduce risks or unexpected variations into the final drug product.

Challenges In The Development Of Pharmaceutical Excipients

The lack of harmonized standards and requirements for assessing safety can delay the process of drug development and approval. Time and cost for developing new excipients is another challenge. As of now, there is no specific approval process for excipients. Their regulatory assessment is linked to their proposed use in a medicinal product and the requirements of the jurisdiction that applies.

Conclusion

Excipients may not provide the main therapeutic effect of a medicine. However, they are important for quality, stability, performance, and patient acceptability. That’s why their safety and suitability need to be considered as carefully as those of the active ingredient.

Pharmaceutical manufacturers should choose the right excipient, which means looking beyond its function. Its quality, compatibility, intended use, quantity, and patient population– everything matters. With appropriate quality controls and risk assessment, excipients can support the development of safe, effective, and consistent drug products.

Proper planning and expertise can help overcome the challenges in the development of pharmaceutical excipients. Artixio Consulting consists of a team of members with knowledge and years of expertise and can provide you with all the support that we can. Find out more about us by connecting with us through info@artixio.com.

FAQs

1. Why are excipients crucial in formulations?

Excipients are added to formulations to help in the manufacturing process, administration and also improving the delivery of the medicine. Excipients are used accordingly based on their functionality. E.g., Flavoring agents are added to mask the bitter taste of the drug.

2. Are pharmaceutical excipients safe to consume?

Most of them are, yes. They’re picked because they don’t interfere with the medicine itself. That said, every excipient goes through safety checks before being cleared for use. The only catch is with kids, especially newborns, since their organs are still developing — in those cases, the amount and type of excipients need extra attention.

3. What do excipients do in controlled-release medicines?

They’re basically what makes a “slow-release” or “extended-release” pill work. The excipient controls how fast the drug comes out once it’s taken — sometimes stretching it out over several hours, sometimes targeting it to a certain part of the body. Done right, it means steadier results and fewer side effects.

4. Can excipients interact with active pharmaceutical ingredients (APIs)?

Yes, interactions between excipients with API can occur. This can affect the stability and bioavailability and ultimately affect the efficacy of the drug product. Excipient – excipient interaction is also possible.

5. What are the latest innovations in pharmaceutical excipients?

Recent advancements include co-processed excipients, 3D printing, smart excipients that respond to specific stimuli, and functional excipients.

Get in touch

×